Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Will Merck's Failure With Tredaptive Impact How Drugs Are Approved in Europe?
Forbes
Wednesday, January 2, 2013 - 11:47am
tags:
Merck, Tredaptive, Europe
Achillion: Poised For Growth And Now Is The Time To Buy
Seeking Alpha
Wednesday, January 2, 2013 - 11:47am
tags:
Achillion, Abbott Labs, Bristol-Myers Squibb, Gilead, Merck, Pfizer, Vertex Pharmaceuticals
Drug Approvals Reach 15-Year High on Smoother FDA Reviews
Bloomberg
Wednesday, January 2, 2013 - 11:46am
tags:
drug approvals, FDA
What 2013 Has in Store for Johnson & Johnson
Motley Fool
Wednesday, January 2, 2013 - 11:45am
tags:
JNJ
2 Drug Companies That Belong In Your Portfolio
Seeking Alpha
Wednesday, January 2, 2013 - 11:45am
tags:
AstraZeneca, Novartis
The 2013 Outlook for GlaxoSmithKline
Motley Fool
Wednesday, January 2, 2013 - 11:44am
tags:
GSK
FDA Approves Covidien Drug
Yahoo/Zacks
Wednesday, January 2, 2013 - 11:43am
tags:
FDA, Mallinckrodt, Covidien, Concerta, ADHD, generics
Is Prolor Biotech As Long Lasting As Its CTP Technology?
Seeking Alpha
Tuesday, January 1, 2013 - 11:55am
tags:
Prolor Biotech, CTP techonology, Merck
Better Than Lipitor! Higher Sales?
Motley Fool
Tuesday, January 1, 2013 - 11:53am
tags:
Pfizer, Lipitor, Juxtapid, Aegerion, Kynamro, Sanofi, Isis Pharmaceuticals, Regeneron, Alnylam, PCSK9 inhibitors
Salix scores FDA approval for HIV-related diarrhea drug Fulyzaq
FierceMedicalDevice
Monday, December 31, 2012 - 4:56pm
tags:
Salix, FDA, HIV
Another Generic Launch at Mylan
Yahoo/Zacks
Monday, December 31, 2012 - 4:50pm
tags:
Generic, launch, Mylan
Pipeline Progress at Synergy Pharma
Yahoo/Zacks
Monday, December 31, 2012 - 4:49pm
tags:
pipelines, Synergy Pharmaceuticals
Acquisition of Complete Genomics by Chinese Company Gets Green Light
The Motley Fool
Monday, December 31, 2012 - 4:44pm
tags:
M&A, Complete Genomics, China, BGI-Shenzhen
2 Biotech Short-Squeeze Candidates For The New Year
Seeking Alpha
Monday, December 31, 2012 - 4:43pm
tags:
biotech, Questcor Pharmaceuticals, Spectrum Pharmaceuticals
2013 Should Be Interesting for Multiple Sclerosis Drugs
The Motley Fool
Monday, December 31, 2012 - 4:36pm
tags:
multiple sclerosis, drugs, Teva Pharmaceuticals, Pfizer, Merck, Biogen, Bayer, Novartis
The Top Pharma Acquisitions of 2012
The Motley Fool
Monday, December 31, 2012 - 4:35pm
tags:
Pharma, M&A, Bristol-Myers Squibb, AstraZeneca, GlaxoSmithKline
J&J Tuberculosis Drug Gets Fast-Track Clearance
Wall Street Journal
Monday, December 31, 2012 - 4:33pm
tags:
J&J, Johnson & Johnson, FDA, tuberculosis, regulatory
Medical devices companies in 2012: The year of the layoff
Mass Device
Monday, December 31, 2012 - 4:17pm
tags:
devices, layoffs, Management
FDA action forces Invacare layoffs
FierceMedicalDevice
Monday, December 31, 2012 - 4:16pm
tags:
FDA, Invacare, layoffs, Management, devices
FDA confronts Mindray over patient monitor quality control
FierceMedicalDevice
Monday, December 31, 2012 - 4:15pm
tags:
FDA, Mindray, patient, safety, regulatory, devices

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.